The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarthritis patients treated with IL-17A (secukinumab) or TNF inhibitors over 2 years. Key findings: - New syndesmophytes: 18.2% (SEC 150 mg), 15.8% (SEC 300 mg),… https://t.co/jke6OHdPjZ

• https://x.com/i/web/status/1858151857870315827

The 3-4-5 rule for positive MRI in axSpA remains. The MRI lesion cut-offs demonstrated high performance across different features of axSpA (PsO, AAU,IBD). Deep fat and deep sclerosis high specificity for axSpA. #Abst0821 #ACR24 @RheumNow https://t.co/4JM5MHrB8z

• https://x.com/AdelaCastro222/status/1858140534877163685/photo/1
• https://x.com/AdelaCastro222/status/1858140534877163685/photo/1

The DESIR cohort of Dr. Franc et al. showed that female pts with early axSpA had significantly lower AMH levels vs. general population reflecting low ovarian reserve & fertility. Mechanism? Bigger studies need to be done @RheumNow #ACR24 abs577 https://t.co/842rX79bq6

• https://x.com/RHEUMarampa/status/1858033142000452013/photo/1